The benign biliary tract tumor is rarely found in clinical practice. One case of bile duct adenomyoma was recently reported in the January 28 issue of the World Journal of Gastroenterology. This paper cited studies on how to differentiate it pre-operatively, and may be helpful to surgeons and beneficial to patients.
The paper described a patient who presented to Dr. Gui-Ming Shu of Tianjin Third Central Hospital, affiliated to Tianjin Medical University, China, in 2005. The patient presented with yellow skin and sclera and complained of itching for two months. He suffered from anorexia and occasional nausea. Tea colored urine, yellowish white feces and weight loss of 2.5 kg were found.
Nothing special was found in the physical examination except the yellowish skin and sclera. Then Computerized Tomography (CT), Magnetic resonance cholangiopancreatography (MRCP), ultrasonography and blood biochemistry examinations were performed, presenting a suspected tumor of the distal bile duct. Later, the patient was treated successfully by pancreaticoduodenectomy.
Histologically, the tumor was adenomyoma, a seldom found benign disease of the bile duct. The patient has been well without any evidence of recurrence for 12 months since his operation.
Source: World Journal of Gastroenterology
Related stories:
Combining liver cancer treatments doubles survival rates, researchers find
By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct.
Study looks at off-label use of biliary stents
Although approved by the U.S. Food and Drug Administration as a palliative treatment for cancer patients who have developed bile-duct obstructions, biliary stents are sometimes used “off-label” for the treatment of peripheral vascular disease (PVD). A study in today’s issue of the
American Journal of Therapeutics finds that off-label use of biliary stents is increasing, and that the majority of adverse events and device malfunctions associated with the use of these stents occurs during off-label usage.
Exclusion of common bile duct stones prior to gallstone operations
In the era of laparoscopic surgery, intra-operative X-ray investigation of bile ducts to identify coexisting common bile duct stones has been replaced by new techniques, which, unfortunately, are either too expensive and not available to all patients, or invasive and may result in severe complications. A study recently reported in the Nov. 21 issue of the
World Journal of Gastroenterology may offer a simple and available measure to solve this problem worldwide.
Physicians Stop Liver Cancer with Millions of Glass Beads
University of Cincinnati (UC) physicians are using a new technique that involves injecting patients with millions of tiny radioactive glass beads to control advanced, inoperable liver cancer.
Researchers find a new role for a 'Foxy Old Gene'
Researchers at the University of Pennsylvania School of Medicine have discovered that a protein called FOXA2 controls genes that maintain the proper level of bile in the liver. FOXA2 may become the focus for new therapies to treat diseases that involve the regulation of bile salts. The study was published online this week in
Nature Medicine.
New technique improves outcome for living donor liver transplants
The University of Alberta Hospital (UAH) is one of only a few centers in Canada that perform living donor liver transplantation, a surgical procedure developed in the late 1980s that expands the organ donor pool. About 80 liver transplants are done a year in Alberta, 10 of those being living-donor.
How to effectively avoid many common complications and liver damage in bile duct exploration?
Micro-wound operation is becoming the trend in surgery in the 21st century and laparoscopic surgery is regarded as an important component of micro-wound surgery.
Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients
A combined therapeutic approach of stenting and photodynamic therapy may improve survival rates for patients suffering from advanced liver bile duct cancer, according to a study published this month in
Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.